What to Expect from the Report

The 2022 ESMO Annual Meeting is over, but the connections, data, and information shared at the conference will stay with us. Our team of analysts have carefully screened all the ESMO 2022 abstracts and identified 18 (17 clinical, 1 preclinical) abstracts relating to Cancer Vaccine drugs and trials, and added them to the Beacon Cancer Vaccine database.

This report encompasses a detailed analysis of the 18 abstracts in the cancer vaccine space, including; clinical abstracts by phase, trial outline summaries and preclinical and clinical abstract summaries.

You will also find a full summary of all 18 cancer vaccine abstracts ordered by; therapeutic class/vaccine type, antigen class and disease indication. The abstract summaries include the following data; the name and link to the drug (on Beacon), trial sponsor/developer, abstract/ trial ID, phase, disease indication and description/dosing.

Find out more


This insight and data is part of the subscription to Beacon Cancer Vaccine.

Cancer Vaccine Logo 2021


Find out more

Speak with our Team

Our dedicated team can help you with questions by showing you how this insight and data is collated on Beacon.


Request a Demo

About Beacon Targeted Therapies

We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.


Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more